Antibiotic resistance is one of the greatest global health threats of our time. While developing new antibiotic drugs is one means of preventing unnecessary deaths from bacterial infections, the medtech sector has a pivotal role to play in ensuring that existing antibiotics are used responsibly.
Such could be the case for urinary tract infections (UTIs), which according to data provided by the National Institute for health and Care Excellence (NICE) account for around one-fifth of...
Four innovative diagnostic tests for UTIs were identified by NICE as having the potential for conditional reimbursement in England in recent draft guidance by its early value assessment (EVA)...